Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progress and challenges in TB vaccine development.
Voss G, Casimiro D, Neyrolles O, Williams A, Kaufmann SHE, McShane H, Hatherill M, Fletcher HA. Voss G, et al. F1000Res. 2018 Feb 16;7:199. doi: 10.12688/f1000research.13588.1. eCollection 2018. F1000Res. 2018. PMID: 29568497 Free PMC article. Review.
The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.
Roordink D, Williams A, Fritzell B, Laddy DJ, Gerdil E, Graffin AM, Tait D, van der Pol L, van den Brink I, Holleman M, Thole J, Voss G, Lempicki M, Thiry G. Roordink D, et al. Among authors: voss g. Tuberculosis (Edinb). 2021 Jan;126:102040. doi: 10.1016/j.tube.2020.102040. Epub 2020 Dec 8. Tuberculosis (Edinb). 2021. PMID: 33310626 Free PMC article.
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B. Kochhar S, et al. Among authors: voss g. Vaccine. 2022 Mar 15;40(12):1681-1690. doi: 10.1016/j.vaccine.2021.10.062. Epub 2022 Feb 11. Vaccine. 2022. PMID: 35164990 Free PMC article.
New hope for tuberculosis vaccines.
Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH. Olesen OF, et al. Among authors: voss gh. Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. Lancet Infect Dis. 2019. PMID: 31250810 No abstract available.
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Voss G, Jacquet JM, Tornieporth N, Kampmann B, Karron R, Meulen AS, Chen R, Gruber M, Lurie N, Weller C, Cramer JP, Saville M, Darko M. Voss G, et al. Vaccine. 2021 Dec 17;39(51):7357-7362. doi: 10.1016/j.vaccine.2021.10.048. Epub 2021 Nov 17. Vaccine. 2021. PMID: 34799142 Free PMC article.
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
Ciapponi A, Bardach A, Mazzoni A, Alconada T, Anderson SA, Argento FJ, Ballivian J, Bok K, Comandé D, Erbelding E, Goucher E, Kampmann B, Karron R, Munoz FM, Palermo MC, Parker EPK, Rodriguez Cairoli F, Santa María V, Stergachis AS, Voss G, Xiong X, Zamora N, Zaraa S, Berrueta M, Buekens PM. Ciapponi A, et al. Among authors: voss g. Vaccine. 2021 Sep 24;39(40):5891-5908. doi: 10.1016/j.vaccine.2021.08.034. Epub 2021 Aug 13. Vaccine. 2021. PMID: 34489131 Free PMC article. Review.
Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults.
Kester KE, Gray Heppner D Jr, Moris P, Ofori-Anyinam O, Krzych U, Tornieporth N, McKinney D, Delchambre M, Ockenhouse CF, Voss G, Holland C, Beckey JP, Ballou WR, Cohen J; RTS,S/TRAP Group. Kester KE, et al. Among authors: voss g. Vaccine. 2014 Nov 20;32(49):6683-91. doi: 10.1016/j.vaccine.2014.06.033. Epub 2014 Jun 18. Vaccine. 2014. PMID: 24950358 Free article. Clinical Trial.
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B. Rollman E, et al. Among authors: voss g. Vaccine. 2007 Mar 1;25(11):2145-54. doi: 10.1016/j.vaccine.2006.10.057. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17254672
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG Jr, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA Jr, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group. Kester KE, et al. Among authors: voss g. Vaccine. 2007 Jul 20;25(29):5359-66. doi: 10.1016/j.vaccine.2007.05.005. Epub 2007 May 30. Vaccine. 2007. PMID: 17574311 Clinical Trial.
258 results